Regulation Network of Colorectal-Cancer-Specific Enhancers in the Progression of Colorectal Cancer

Bohan Chen, Ma Yi-ping, Jinfang Bi, Wenbin Wang, Anshun He, Guangsong Su, Zhongfang Zhao, Jiandang Shi, Lei ZhangInternational Journal of Molecular Sciences 2021 · DOI

TL;DR

This study uncovers a network of "cancer-specific enhancers" that are uniquely active in colorectal cancer cells, driving the expression of key genes involved in tumor progression. By integrating HiChIP, Hi-C, and RNA-seq data, the researchers map how these enhancers interact with target genes through higher-order chromatin structures, offering potential new therapeutic targets.

What Problem Does This Paper Address?

Colorectal cancer (CRC) is a major health concern, and while genetic mutations and chromosomal instability are known drivers, the role of regulatory elements like enhancers in its progression is less understood. Specifically, it's unclear how "cancer-specific enhancers" – those active in cancer cells but not normal cells – function and form regulatory networks that influence CRC development. Identifying these networks is crucial for understanding CRC pathogenesis and for developing targeted therapies.

Methods

The researchers employed a multi-pronged approach:

  • H3K27ac ChIP-seq Analysis: Used to identify active enhancers by analyzing histone modification patterns in colorectal cancer and normal colon tissue samples. Unsupervised hierarchical clustering helped distinguish tissue-specific enhancers.
  • HiChIP: Performed on a colorectal cancer cell line (HCT116) to map three-dimensional chromatin interactions, specifically focusing on enhancer-promoter loops. This technique allows for the identification of long-range interactions.
  • Hi-C Data Analysis: Utilized existing Hi-C datasets from colorectal cancer and normal colon tissues to analyze changes in Topological Associated Domains (TADs), which are fundamental units of genome organization.
  • RNA-seq Data Analysis: Employed TCGA and GEPIA datasets to compare gene expression profiles between normal colon and colorectal cancer tissues, identifying significantly up- and down-regulated genes.
  • In Silico Integration: Combined data from HiChIP, Hi-C, and RNA-seq to build a comprehensive picture of how colorectal-cancer-specific enhancers interact with genes and influence their expression in the context of altered chromatin structures.
  • Pathway Enrichment Analysis (Metascape): Used to understand the biological functions and pathways enriched among the target genes regulated by these enhancers.

Datasets

  • H3K27ac ChIP-seq datasets: From seven colorectal cancer samples and ten normal colon tissue samples (obtained from Roadmap Epigenomics, ENCODE, and a previously published study).
  • Hi-C data: From two datasets representing colorectal cancer tissue and normal colon tissue (GSE133928, BRD3179, and BRD3179N).
  • RNA-seq data: From TCGA and GEPIA databases for gene expression analysis.
  • HiChIP data: Generated in-house from the HCT116 colorectal cancer cell line.

Key Insights and Ideas

  • Cancer-Specific Enhancers Drive CRC Progression: The study strongly suggests that a distinct set of enhancers becomes active in colorectal cancer cells, playing a significant role in tumor development and progression.
  • Higher-Order Chromatin Structures are Key: These cancer-specific enhancers don't act in isolation; they engage in long-range interactions with target genes through complex three-dimensional chromatin structures (TADs and loops).
  • TADs are Reorganized in CRC: A substantial portion of TAD boundaries are altered in colorectal cancer cells compared to normal cells, and these altered TADs are frequently associated with colorectal-cancer-specific enhancers.
  • Target Genes are Crucial Cancer Drivers: The genes regulated by these enhancers include known cancer-driver genes like ITGB4, RECQL4, MSLN, and GDF15, which are often upregulated in CRC and implicated in key cellular processes like migration, proliferation, and resistance to therapy.
  • Potential for Targeted Therapies: The identification of these specific enhancer-gene regulatory networks opens avenues for developing novel therapeutic strategies that target these unique regulatory elements or their interactions.

Key Results

  • Identification of Enhancers: Identified 21,132 normal colon-tissue-specific enhancers and 11,463 colorectal-cancer-specific enhancers.
  • Distinct Enhancer Profiles: t-SNE analysis clearly separated colorectal cancer enhancer profiles from normal colon tissue enhancers.
  • Super Enhancers: Identified 763 super enhancers among the colorectal-cancer-specific enhancers, some associated with oncogenes.
  • TAD Alterations: Approximately 65% of TAD boundaries were changed in colorectal cancer cells compared to normal colon cells.
  • Enhancer-TAD Association: Over 50% of these changed TADs contained colorectal-cancer-specific enhancers.
  • Target Gene Interactions: Colorectal-cancer-specific enhancers interact with 152 significantly upregulated genes in colorectal cancer.
  • Long-Range Interactions: About 79% of interactions between cancer-specific enhancers and target genes are long-range (≥20 kb).
  • Key Target Genes: Identified ITGB4, RECQL4, MSLN, and GDF15 as important target genes upregulated in CRC and regulated by these enhancers.

Limitations and Future Work

  • Single Cell Line: The HiChIP data was generated from a single colorectal cancer cell line (HCT116). The authors acknowledge that more in vitro/vivo experiments on larger scales of human tissue samples and mouse models are needed to further validate these findings.
  • Causality: While the study demonstrates associations, it is unclear whether the changes in chromatin topological structures or the activation of colorectal-specific enhancers are the primary events in CRC initiation. Further studies are needed to verify this hypothesis.
  • Key Driver Genes: It remains to be pinpointed whether there are specific key driver genes within the colorectal-cancer-specific enhancer regulation network, or if CRC progression is a combined result of multiple target genes.
  • GALK1 Function: The study suggests GALK1 may be regulated by colorectal-cancer-specific enhancers, but few studies have reported its function in colorectal cancer, indicating a need for further investigation.

The authors propose that manipulating these 3D chromatin structures or specific enhancer-promoter interactions could be a future therapeutic direction for colorectal cancer.

Summary updated

Abstract

Enhancers regulate multiple genes via higher-order chromatin structures, and they further affect cancer progression. Epigenetic changes in cancer cells activate several cancer-specific enhancers that are silenced in normal cells. These cancer-specific enhancers are potential therapeutic targets of cancer. However, the functions and regulation networks of colorectal-cancer-specific enhancers are still unknown. In this study, we profile colorectal-cancer-specific enhancers and reveal their regulation network through the analysis of HiChIP data that were derived from a colorectal cancer cell line and Hi-C and RNA-seq data that were derived from tissue samples by in silico analysis and in vitro experiments. Enhancer-promoter loops in colorectal cancer cells containing colorectal-cancer-specific enhancers are involved in more than 50% of the topological associated domains (TADs) changed in colorectal cancer cells compared to normal colon cells. In addition, colorectal-cancer-specific enhancers interact with 152 genes that are significantly and highly expressed in colorectal cancer cells. These colorectal-cancer-specific enhancer target genes include <i>ITGB4</i>, <i>RECQL4</i>, <i>MSLN</i>, and <i>GDF15</i>. We propose that the regulation network of colorectal-cancer-specific enhancers plays an important role in the progression of colorectal cancer.
BibTeX
@article{chen2021regulation,
  author = {Bohan Chen and MA Yi-ping and Jinfang Bi and Wenbin Wang and Anshun He and Guangsong Su and Zhongfang Zhao and Jiandang Shi and Lei Zhang},
  title = {{Regulation Network of Colorectal-Cancer-Specific Enhancers in the Progression of Colorectal Cancer}},
  journal = {International Journal of Molecular Sciences},
  year = {2021},
  doi = {10.3390/ijms22158337},
}
Figure